India to Germany: Docetaxel Export Trade Route

The India to Germany Docetaxel corridor is one of India's established pharmaceutical export routes, with 147 shipments documented worth a combined $2.5M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's docetaxel manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $17.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with docetaxel's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 10.1%, placing it at rank #18 among India's top docetaxel export destinations globally.

On the import side, key buyers of Indian docetaxel in Germany include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI DEUTSCHLAND GMBH , VENUS PHARMA GMBH . FRESENIUS KABI DEUTSCHLAND GMBH is the single largest importer with 105 shipments valued at $1.9M USD.

India's docetaxel exports to Germany are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 105 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , VENUS REMEDIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $17.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as docetaxel kabi inj. 160mg/8ml vial,batc and docetaxel kabi inj. 160mg/8ml vial ite, suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI DEUTSCHLAND GMBH is the largest importer with 105 shipments worth $1.9M USD — representing 76% of all docetaxel imports from India on this route.